References
- Valagussa P. Second neoplasms following treatment of Hodgkin's disease. Curr Op Oncol 1993; 5: 805–11
- Munker R, Schmidt M, Christel K, Hölzel D, Hiller E. Sekundäre Malignome bei Patienten mil M Hodgkin in Vollremission. Eine Zwischenbilanz. Deutsch Med Wochenschr 1995; 120: 51–4
- Boivin J F, Hutchison G B, Lubin J H, Mauch P. Coronary artery disease in patients treated for Hodgkin's disease. Cancer 1992; 69: 1241–7
- Hancock S LL, Donaldson S S, Hoppe R T. Cardiac disease following treatment of Hodgkin's disease in children and adolescents. J Clin Oncol 1993; 11: 1208–15
- Chinnasami B R, Schwartz R C, Pink S B, Skotnicki R A. Isolated left main coronary stenosis and mediastinal irradiation. Clin Cardiol 1992; 15: 459–61
- Glanzmann C, Lütolf U M. Fragen und Aspekte zur Radio-therapie bei Erwachsenen mit lokalisierten supradiaphragmalen Stadien CS I/II eines M Hodgkin. Teil 2 Spezielle Aspekte. Strahlenther Onkol 1992; 169: 570–83
- Kreuser E D, Völler H, Behles C, et al. Evaluation of late cardiotoxicity with pulsed Doppler echo-cardiography in patients treated for Hodgkin's disease. Br J Haematol 1993; 84: 615–22
- Lipid Research Clinics Program Epidemiology Committee. Plasma lipid distributions in selected North American populations: The lipid research clinics program prevalence study. Circulation 1979; 60: 427–39
- Assmann G. Lipidstoffwechsel und Arteriosklerose. Stuttgart. Schattauer, New York 1982
- Richter W O, Möhrle W, Schwandt P. Cholesterinwerte in der Bayerischen Bevölkerung. Münchn Med Wochenschr 1992; 134: 361–4
- Grover S A, Palmer C S, Coupal L. Serum lipid screening to identify high-risk individuals for coronary death. Arch Intern Med 1994; 154: 679–84
- Muller C P, Trilling B, Steinke B. The prognostic significance of total serum cholesterol in patients with Hodgkin's disease. Cancer 1992; 69: 1042–6
- Boyer M, Raghavan D, Harris P J, et al. Lack of late toxicity in patients treated with cis-platinum containing combination chemotherapy for metastatic testicularcancer. J Clin Oncol 1990; 8: 21–6
- Gietema J A, Sleeifer D T, Willemse P HB, et al. Long-term follow-up of cardiovascular risk factors in patients given chemotherapy for disseminated nonseminomatous testicular cancer. Ann Int Med 1992; 116: 709–15
- Ellis P A, Fitzharris B M, George P M, Robinson B A, Atkinson C H, Colls B M. Fasting plasma lipid measurements following cisplatin chemotherapy in patients with germ cell tumors. J Clin Oncol 1992; 10: 1609–14
- Corn B W, Trock B J, Goodmann R J. Radiation related ischemic heart disease. J Clin Oncol 1990; 8: 741–50
- Austin M A, Hokanson J E. Epidemiology of triglycerides, small dense low-density lipoprotein and lipoprotein(a) as risk factors for coronary heart disease. Med Clin NA 1994; 78: 99–115